tiprankstipranks
Trending News
More News >
RUA Life Sciences (GB:RUA)
LSE:RUA

RUA Life Sciences (RUA) Price & Analysis

Compare
3 Followers

RUA Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

1.67%98.33%
Mutual Funds
― Other Institutional Investors
98.33% Public Companies and
Individual Investors

RUA FAQ

What was RUA Life Sciences’s price range in the past 12 months?
RUA Life Sciences lowest share price was 10.01p and its highest was 15.70p in the past 12 months.
    What is RUA Life Sciences’s market cap?
    RUA Life Sciences’s market cap is £7.29M.
      When is RUA Life Sciences’s upcoming earnings report date?
      RUA Life Sciences’s upcoming earnings report date is Dec 11, 2025 which is in 152 days.
        How were RUA Life Sciences’s earnings last quarter?
        RUA Life Sciences released its earnings results on Jun 25, 2025. The company reported -0.01p earnings per share for the quarter, missing the consensus estimate of N/A by -0.01p.
          Is RUA Life Sciences overvalued?
          According to Wall Street analysts RUA Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does RUA Life Sciences pay dividends?
            RUA Life Sciences does not currently pay dividends.
            What is RUA Life Sciences’s EPS estimate?
            RUA Life Sciences’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does RUA Life Sciences have?
            RUA Life Sciences has 62,060,272 shares outstanding.
              What happened to RUA Life Sciences’s price movement after its last earnings report?
              RUA Life Sciences reported an EPS of -0.01p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.982%.
                Which hedge fund is a major shareholder of RUA Life Sciences?
                Currently, no hedge funds are holding shares in GB:RUA

                Company Description

                RUA Life Sciences

                RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.
                Similar Stocks
                Company
                Price & Change
                Follow
                MyHealthChecked PLC
                Inspiration Healthcare
                Oxford BioDynamics
                HemoGenyx Pharmaceuticals Plc
                Surgical Innovations
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis